MI Bioresearch has been sold to Covance, a subsidiary of LabCorp
MI Bioresearch is a leading preclinical immuno-oncology / oncology contract research organization, offering a unique combination of complementary services. It supports preclinical research for a diverse pharmaceutical and biotechnology customer base. It offers a broad range of human cell line and syngeneic models, supported by an array of in vitro services, in vivo pharmacology, in vivo imaging and focal beam radiation. MI Bioresearch’s comprehensive, differentiated business model leverages this range of services to better interrogate the complex pharmacology associated with cancer to provide higher-quality, decision-enabling data to its customers. For more information, visit www.mibioresearch.com.
Lincoln International acted as the exclusive investment banking advisor for MI Bioresearch and its shareholders, working closely with the company’s management team and shareholders throughout the sale process. This included creating a customized process strategy, developing the positioning, managing the buyer outreach, organizing due diligence and negotiating the transaction.
Covance is a comprehensive drug development company. Covance offers laboratory testing services to the chemical / agrochemical industries and is a market leader in toxicology services, central laboratory services, discovery services and a top global provider of Phase III clinical trial management services. For more information, visit www.covance.com.
LabCorp, an S&P 500 listed company, is a leading life sciences company, providing comprehensive clinical laboratory and end-to-end drug development services. LabCorp delivers diagnostic solutions, brings innovative medicines to patients and develops technology-enabled solutions. For more information, visit www.labcorp.com.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International is pleased to announce that Endoscopy Development Company has been sold to Healthcare Components Group, a portfolio Company of RoundTable Healthcare Partners
Lincoln International is pleased to announce that Criatec has successfully divested its stake in Imeve Indústria de Medicamentos Veterinários to private shareholders
Lincoln International is pleased to announce that it has advised Lighthouse Lab Services, a portfolio company of NaviMed Capital, for its majority growth recapitalization with Martis Capital
Lincoln International is pleased to announce that ATDBio has been sold to Biotage
Lincoln International is pleased to announce that KIMS Hospital has been sold to LycaHealth
Lincoln International is pleased to announce that ARK Agency has been sold to OPEN Health, a portfolio company of Amulet Capital Partners
Lincoln International is pleased to announce that Hg has madea strategic investment in HHAeXchange
Lincoln International is pleased to announce that Bridges Fund Management has sold The Vet to CVS Group plc